Top Buy
| Security ▲ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | 39 | 0 | 2 | 0 | €107.36 | €127.60 | 18.852% |
| AbbVie Inc. | 37 | 0 | 4 | 0 | €194.20 | €209.13 | 7.688% |
| Abivax S.A. | 3 | 1 | 0 | 0 | €97.70 | - | - |
| Acadia Pharmaceuticals | 27 | 1 | 4 | 0 | €23.57 | €27.38 | 16.161% |
| AC Immune Ltd | 6 | 0 | 0 | 0 | €2.42 | €10.61 | 338.545% |
| Addus Homecare Corp. | 16 | 1 | 1 | 0 | €99.50 | €121.14 | 21.751% |
| Agilent Technologies Inc. | 23 | 0 | 6 | 0 | €124.90 | €140.88 | 12.791% |
| Agios Pharmaceuticals Inc. | 11 | 1 | 6 | 0 | €24.00 | €43.63 | 81.773% |
| Akebia Therapeutics Inc. | 12 | 1 | 2 | 0 | €1.35 | €6.16 | 358.016% |
| Akero Therapeutics Inc | 11 | 2 | 0 | 0 | €46.84 | €68.61 | 46.475% |
| Align Technology | 23 | 1 | 1 | 0 | €135.05 | €215.11 | 59.282% |
| Alkermes plc | 17 | 0 | 4 | 0 | €25.00 | €38.70 | 54.809% |
| Alnylam Pharmace. | 51 | 0 | 0 | 0 | €393.40 | €456.30 | 15.988% |
| Alphatec Holdings Inc | 2 | 0 | 2 | 0 | €18.28 | - | - |
| Alterity Therapeutics Ltd. ADR | 1 | 0 | 0 | 0 | €2.68 | €7.64 | 184.896% |
| Amedisys Inc. | 1 | 0 | 0 | 0 | €84.50 | €88.29 | 4.485% |
| Amgen Inc. | 25 | 4 | 7 | 0 | €283.30 | €296.66 | 4.716% |
| Amicus Therapeutics Inc. | 5 | 0 | 1 | 0 | €8.30 | €16.39 | 97.448% |
| AnaptysBio Inc | 24 | 0 | 5 | 0 | €36.60 | €44.30 | 21.048% |
| Angiodynamics Inc. | 1 | 0 | 0 | 0 | €11.30 | €13.00 | 15.044% |
| Anika Therapeutics | 9 | 0 | 1 | 0 | €8.05 | €15.41 | 91.476% |
| Anthem Inc. | 2 | 0 | 0 | 0 | €284.00 | €450.00 | 58.451% |
| Arrowhead Pharmaceuticals Inc. | 19 | 0 | 6 | 0 | €52.76 | €64.41 | 22.087% |
| Astrazeneca ADR | 1 | 0 | 1 | 0 | €77.50 | €80.00 | 3.226% |
| AstraZeneca plc | 3 | 0 | 0 | 0 | €155.10 | €160.25 | 3.320% |